Australia markets closed

Artelo Biosciences, Inc. (ARTL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5250+0.0150 (+0.99%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
31/08/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
3,784
5,696
4,324
2,839
1,919
-
Selling general and administrative
5,633
4,234
5,963
4,602
2,767
-
Total operating expenses
9,417
9,930
10,287
7,441
4,686
-
Operating income or loss
-9,417
-9,930
-10,287
-7,441
-4,686
-
Interest expense
-
0
5
0
-
-
Total other income/expenses net
623
641
207
2
30
-
Income before tax
-9,407
-9,289
-10,083
-7,437
-4,655
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-9,407
-9,289
-10,083
-7,437
-4,655
-
Net income
-9,407
-9,289
-10,083
-7,437
-4,655
-
Net income available to common shareholders
-9,407
-9,289
-10,083
-7,437
-4,655
-
Basic EPS
-3.33
-
-3.56
-5.97
-18.90
-15.00
Diluted EPS
-3.33
-
-3.56
-5.97
-18.90
-15.00
Basic average shares
2,874
-
2,833
1,245
247.176
144.831
Diluted average shares
2,874
-
2,833
1,245
247.176
144.831